Autoclaves incorporate unique advanced surface hygiene coating to combat surface microbial growth.

These autoclaves are set to have a major impact within the hospital, biochemical and pharmaceutical laboratory environments as well as food industry research sectors and many others, as they can dramatically reduce the risks of cross-contamination and cross-infection. Recognition of these hazards has inspired the development of the revolutionary, silver based, BioCote« technology. Incorporated into the exterior surfaces of the equipment, this patent protected technology aids the fight against cross-contamination by inhibiting the growth of a wide range of micro-organisms, including E-Coli, Listeria, Pseudomonas and MRSA on the exterior surfaces of the equipment. Such is the ability of BioCote« to provide a second line of defence, backing up good hygiene practice in areas vulnerable to potential cross-contamination, Priorclave have applied this unique process to their entire range of autoclaves. As the UKÆs largest dedicated manufacturer of autoclaves for the laboratory market, Priorclave believe their exclusive arrangement with BioCote« will enable the Company, and its distributors, to make a major impact into the steriliser market in general. ôAt Priorclave we have always endeavoured to be at the forefront of new technologies to assist the autoclave user, our eventual customer, with getting the best from their autoclaveö says Tony Collins, PriorclaveÆs Managing Director. ôThe addition of BioCote« to our range provides added protection both personally and to the integrity of their work results for people working in the traditional, dirty end of the lab.ö